Morgan Stanley’s Zepp Health ZEPP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.46M | Buy |
707,691
+97,397
| +16% | +$1.99M | ﹤0.01% | 3707 |
|
|
2025
Q4 | $16.4M | Buy |
610,294
+80,780
| +15% | +$2.88M | ﹤0.01% | 3111 |
|
|
2025
Q3 | $24.2M | Buy |
529,514
+497,718
| +1,565% | +$15.1M | ﹤0.01% | 2702 |
|
|
2025
Q2 | $84.6K | Sell |
31,796
-11,755
| -27% | -$30.1K | ﹤0.01% | 6194 |
|
|
2025
Q1 | $129K | Buy |
43,551
+10,183
| +31% | +$30.4K | ﹤0.01% | 5905 |
|
|
2024
Q4 | $86.8K | Sell |
33,368
-7,370
| -18% | -$23.3K | ﹤0.01% | 6108 |
|
|
2024
Q3 | $177K | Buy |
40,738
+6,146
| +18% | +$17.3K | ﹤0.01% | 5794 |
|
|
2024
Q2 | $83K | Buy |
34,592
+14,029
| +68% | +$45.6K | ﹤0.01% | 6027 |
|
|
2024
Q1 | $83.9K | Buy |
20,563
+9,658
| +89% | +$49.8K | ﹤0.01% | 6062 |
|
|
2023
Q4 | $61.9K | Buy |
10,905
+7,186
| +193% | +$36.1K | ﹤0.01% | 6319 |
|
|
2023
Q3 | $17.1K | Sell |
3,719
-23
| -0.6% | -$109 | ﹤0.01% | 6537 |
|
|
2023
Q2 | $17.1K | Sell |
3,742
-3,019
| -45% | -$15.2K | ﹤0.01% | 6619 |
|
|
2023
Q1 | $35.4K | Buy |
6,761
+2,842
| +73% | +$20.1K | ﹤0.01% | 6406 |
|
|
2022
Q4 | $22.7K | Buy |
3,919
+872
| +29% | +$4.67K | ﹤0.01% | 6635 |
|
|
2022
Q3 | $16K | Sell |
3,047
-82,747
| -96% | -$598K | ﹤0.01% | 6898 |
|
|
2022
Q2 | $635K | Sell |
85,794
-26,979
| -24% | -$248K | ﹤0.01% | 5297 |
|
|
2022
Q1 | $1.3M | Buy |
112,773
+7,056
| +7% | +$114K | ﹤0.01% | 4816 |
|
|
2021
Q4 | $2.14M | Buy |
105,717
+78,718
| +292% | +$2.36M | ﹤0.01% | 4531 |
|
|
2021
Q3 | $867K | Sell |
26,999
-15,558
| -37% | -$642K | ﹤0.01% | 5142 |
|
|
2021
Q2 | $2M | Buy |
42,557
+12,554
| +42% | +$523K | ﹤0.01% | 4635 |
|
|
2021
Q1 | $1.29M | Buy |
30,003
+15,990
| +114% | +$929K | ﹤0.01% | 4567 |
|
|
2020
Q4 | $664K | Buy |
14,013
+11,046
| +372% | +$551K | ﹤0.01% | 4903 |
|
|
2020
Q3 | $153K | Sell |
2,967
-240
| -7% | -$13.2K | ﹤0.01% | 5239 |
|
|
2020
Q2 | $159K | Sell |
3,207
-765
| -19% | -$35.3K | ﹤0.01% | 5184 |
|
|
2020
Q1 | $208K | Sell |
3,972
-75,437
| -95% | -$4.08M | ﹤0.01% | 4846 |
|
|
2019
Q4 | $3.82M | Buy |
79,409
+18,737
| +31% | +$786K | ﹤0.01% | 3479 |
|
|
2019
Q3 | $2.43M | Buy |
60,672
+47,822
| +372% | +$2.01M | ﹤0.01% | 3602 |
|
|
2019
Q2 | $514K | Sell |
12,850
-18,590
| -59% | -$776K | ﹤0.01% | 4596 |
|
|
2019
Q1 | $1.65M | Buy |
31,440
+31,427
| +241,746% | +$1.7M | ﹤0.01% | 3745 |
|
|
2018
Q4 | $0 | Sell |
13
-2,343
| -99% | -$92.1K | ﹤0.01% | 6754 |
|
|
2018
Q3 | $101K | Buy |
2,356
+728
| +45% | +$29.3K | ﹤0.01% | 5685 |
|
|
2018
Q2 | $64K | Sell |
1,628
-27,421
| -94% | -$1.13M | ﹤0.01% | 5854 |
|
|
2018
Q1 | $1.24M | Buy |
+29,049
| New | +$1.29M | ﹤0.01% | 4396 |
|
Other funds holding ZEPP
MM
YCM
Morgan Stanley's ZEPP Position: Q1 2026 in Review
Morgan Stanley increased its Zepp Health (ZEPP) stake by 16% in Q1 2026, buying an estimated $1.99M and bringing the position to 707,691 shares worth $8.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3707.
Morgan Stanley first reported a position in ZEPP in Q1 2018 and has held it in 33 quarters since. The position peaked at $24.2M in Q3 2025. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.
- Morgan Stanley held 707,691 shares of Zepp Health worth $8.46M as of Q1 2026.
- Morgan Stanley bought 97,397 Zepp Health shares in Q1 2026, an estimated $1.99M.
- Zepp Health made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3707 holding.
- Morgan Stanley first reported a position in Zepp Health in Q1 2018 and has held it in 33 quarters since.
- Morgan Stanley's Zepp Health position peaked at $24.2M in Q3 2025.
- 32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.